HuVePharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HuVePharma
Largest movements
- Intangible fixed assets +€7.1m
up €7.1m (+15.0%), from €47.6m to €54.8m
- Stocks and contracts +€2.1m
up €2.1m (+7.8%), from €26.5m to €28.5m
- Receivables within one year +€2.1m
up €2.1m (+14.2%), from €14.5m to €16.6m
of which Trade receivables: +€2.6m
- Cash -€1.2m
down €1.2m (-20.8%), from €5.8m to €4.6m
mainly Investment in fixed assets (net) (-€20.3m) and Stocks and contracts (-€2.1m)
- Profit (loss) carried forward +€4.9m
up €4.9m (+18.5%), from €26.5m to €31.4m
- Accrued charges and deferred income +€2.0m
up €2.0m (+36.1%), from €5.4m to €7.4m
- Trade debts +€1.5m
up €1.5m (+3.2%), from €45.8m to €47.2m
- Turnover +€12.1m
up €12.1m (+10.5%), from €115.0m to €127.1m
- Goods and materials +€10.1m
up €10.1m (+11.1%), from €90.7m to €100.8m
of which Purchases: +€7.9m
- Other operating income +€9.5m
up €9.5m (+27.7%), from €34.4m to €44.0m
- Staff costs +€4.9m
up €4.9m (+41.0%), from €12.0m to €16.9m
- Services and other goods +€3.9m
up €3.9m (+12.9%), from €30.3m to €34.3m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €97,540,285 | €107,689,018 | +€10.1m | +10.4% |
| Fixed assets | 21/28 | €48,734,434 | €55,932,633 | +€7.2m | +14.8% |
| Intangible fixed assets | 21 | €47,616,309 | €54,762,925 | +€7.1m | +15.0% |
| Tangible fixed assets | 22/27 | €829,193 | €934,599 | +€105,406 | +12.7% |
| Plant, machinery and equipment | 23 | €234,371 | €221,428 | -€12,943 | -5.5% |
| Furniture and vehicles | 24 | €142,864 | €168,446 | +€25,581 | +17.9% |
| Other tangible fixed assets | 26 | €451,958 | €544,726 | +€92,768 | +20.5% |
| Financial fixed assets | 28 | €288,932 | €235,109 | -€53,824 | -18.6% |
| Affiliated companies | 280/1 | €1,000 | €1,000 | = | 0.0% |
| Participating interests | 280 | €1,000 | €1,000 | = | 0.0% |
| Other financial fixed assets | 284/8 | €287,932 | €234,109 | -€53,824 | -18.7% |
| Amounts receivable and cash guarantees | 285/8 | €287,932 | €234,109 | -€53,824 | -18.7% |
| Current assets | 29/58 | €48,805,851 | €51,756,385 | +€3.0m | +6.0% |
| Amounts receivable after more than one year | 29 | €4,586 | €8,451 | +€3,865 | +84.3% |
| Other amounts receivable | 291 | €4,586 | €8,451 | +€3,865 | +84.3% |
| Stocks and contracts in progress | 3 | €26,477,796 | €28,548,483 | +€2.1m | +7.8% |
| Stocks | 30/36 | €26,477,796 | €28,548,483 | +€2.1m | +7.8% |
| Goods purchased for resale | 34 | €26,477,796 | €28,548,483 | +€2.1m | +7.8% |
| Amounts receivable within one year | 40/41 | €14,546,909 | €16,611,446 | +€2.1m | +14.2% |
| Trade receivables | 40 | €13,338,545 | €15,941,226 | +€2.6m | +19.5% |
| Other amounts receivable | 41 | €1,208,365 | €670,220 | -€538,144 | -44.5% |
| Current investments | 50/53 | €17,893 | - | -€17,893 | |
| Other investments | 51/53 | €17,893 | - | -€17,893 | |
| Cash at bank and in hand | 54/58 | €5,797,695 | €4,591,821 | -€1.2m | -20.8% |
| Deferred charges and accrued income | 490/1 | €1,960,971 | €1,996,184 | +€35,213 | +1.8% |
| Total equity and liabilities | 10/49 | €97,540,285 | €107,689,018 | +€10.1m | +10.4% |
| Equity | 10/15 | €43,887,104 | €49,777,357 | +€5.9m | +13.4% |
| Contributions | 10/11 | €4,500,000 | €4,500,000 | = | 0.0% |
| Capital | 10 | €4,500,000 | €4,500,000 | = | 0.0% |
| Issued capital | 100 | €4,500,000 | €4,500,000 | = | 0.0% |
| Reserves | 13 | €12,864,549 | €13,853,899 | +€989,350 | +7.7% |
| Non-distributable reserves | 130/1 | €450,000 | €450,000 | = | 0.0% |
| Legal reserve | 130 | €450,000 | €450,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €5,241,450 | €3,967,925 | -€1.3m | -24.3% |
| Distributable reserves | 133 | €7,173,099 | €9,435,974 | +€2.3m | +31.5% |
| Profit (loss) carried forward | 14 | €26,522,555 | €31,423,458 | +€4.9m | +18.5% |
| Amounts payable | 17/49 | €53,653,181 | €57,911,661 | +€4.3m | +7.9% |
| Amounts payable after more than one year | 17 | €86,781 | €27,857 | -€58,924 | -67.9% |
| Financial debts | 170/4 | €86,781 | €27,857 | -€58,924 | -67.9% |
| Leasing and similar obligations | 172 | €86,781 | €27,857 | -€58,924 | -67.9% |
| Amounts payable within one year | 42/48 | €48,139,351 | €50,500,183 | +€2.4m | +4.9% |
| Current portion of amounts payable after more than one year | 42 | €98,522 | €79,206 | -€19,316 | -19.6% |
| Trade debts | 44 | €45,756,302 | €47,211,169 | +€1.5m | +3.2% |
| Suppliers | 440/4 | €45,756,302 | €47,211,169 | +€1.5m | +3.2% |
| Advances received on contracts in progress | 46 | €89,700 | - | -€89,700 | |
| Taxes, remuneration and social security | 45 | €2,077,327 | €3,092,308 | +€1.0m | +48.9% |
| Taxes | 450/3 | €1,133,544 | €2,043,813 | +€910,269 | +80.3% |
| Remuneration and social security | 454/9 | €943,783 | €1,048,495 | +€104,712 | +11.1% |
| Other amounts payable | 47/48 | €117,500 | €117,500 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €5,427,049 | €7,383,621 | +€2.0m | +36.1% |
| Operating income | 70/76A | €152,590,999 | €174,204,645 | +€21.6m | +14.2% |
| Turnover | 70 | €115,026,597 | €127,095,181 | +€12.1m | +10.5% |
| Own construction capitalised | 72 | €3,129,515 | €3,125,471 | -€4,044 | -0.1% |
| Other operating income | 74 | €34,434,887 | €43,983,994 | +€9.5m | +27.7% |
| Operating charges | 60/66A | €145,746,408 | €165,770,545 | +€20.0m | +13.7% |
| Goods for resale, raw materials and consumables | 60 | €90,729,523 | €100,810,348 | +€10.1m | +11.1% |
| Purchases | 600/8 | €95,007,372 | €102,881,035 | +€7.9m | +8.3% |
| Change in stocks: decrease (increase) | 609 | -€4,277,849 | -€2,070,687 | +€2.2m | +51.6% |
| Services and other goods | 61 | €30,348,572 | €34,266,838 | +€3.9m | +12.9% |
| Remuneration, social security and pensions | 62 | €11,988,476 | €16,902,324 | +€4.9m | +41.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,074,280 | €13,085,213 | +€1.0m | +8.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | -€1,787 | -€1,787 | |
| Other operating charges | 640/8 | €604,532 | €707,578 | +€103,046 | +17.0% |
| Non-recurring operating charges | 66A | €1,025 | €32 | -€993 | -96.9% |
| Operating profit (loss) | 9901 | €6,844,591 | €8,434,100 | +€1.6m | +23.2% |
| Financial income | 75/76B | €370,509 | €532,689 | +€162,179 | +43.8% |
| Recurring financial income | 75 | €370,509 | €532,689 | +€162,179 | +43.8% |
| Income from current assets | 751 | €57,773 | €43,986 | -€13,787 | -23.9% |
| Other financial income | 752/9 | €312,737 | €488,703 | +€175,966 | +56.3% |
| Financial charges | 65/66B | €946,328 | €1,020,945 | +€74,617 | +7.9% |
| Recurring financial charges | 65 | €946,328 | €1,020,945 | +€74,617 | +7.9% |
| Debt charges | 650 | €104,606 | €171,631 | +€67,024 | +64.1% |
| Other financial charges | 652/9 | €841,721 | €849,314 | +€7,593 | +0.9% |
| Profit (loss) for the period before taxes | 9903 | €6,268,773 | €7,945,844 | +€1.7m | +26.8% |
| Income taxes | 67/77 | €1,491,435 | €2,055,591 | +€564,156 | +37.8% |
| Taxes | 670/3 | €1,514,516 | €2,055,591 | +€541,075 | +35.7% |
| Tax adjustments and reversals of tax provisions | 77 | €23,081 | - | -€23,081 | |
| Profit (loss) for the period | 9904 | €4,777,338 | €5,890,253 | +€1.1m | +23.3% |
| Transfer to tax-exempt reserves | 689 | €989,350 | €989,350 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €3,787,988 | €4,900,903 | +€1.1m | +29.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.